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Abstract—Objective: Radiomics-driven Computer Aided Diag-
nosis (CAD) has shown considerable promise in recent years
as a potential tool for improving clinical decision support in
medical oncology, particularly those based around the concept of
Discovery Radiomics, where radiomic sequencers are discovered
through the analysis of medical imaging data. One of the main
limitations with current CAD approaches is that it is very difficult
to gain insight or rationale as to how decisions are made, thus
limiting their utility to clinicians. Methods: In this study, we
propose CLEAR-DR, a novel interpretable CAD system based
on the notion of CLass-Enhanced Attentive Response Discovery
Radiomics for the purpose of clinical decision support for diabetic
retinopathy. Results: In addition to disease grading via the
discovered deep radiomic sequencer, the CLEAR-DR system also
produces a visual interpretation of the decision-making process
to provide better insight and understanding into the decision-
making process of the system. Conclusion: We demonstrate the
effectiveness and utility of the proposed CLEAR-DR system
of enhancing the interpretability of diagnostic grading results
for the application of diabetic retinopathy grading. Significance:
CLEAR-DR can act as a potential powerful tool to address the
uninterpretability issue of current CAD systems, thus improving
their utility to clinicians.
Index Terms—CLEAR, visualization, diabetes, radiomics.
I. INTRODUCTION
Diabetic retinopathy is a medical condition that causes
damage to the retina due to diabetes. It is the leading cause
of blindness in the world. Traditionally, clinical diagnosis
for diseases such as diabetic retinopathy is highly subjective
based purely on a clinician’s experience. As such, these
diagnoses have high inter- and intra-observer variability. The
prevalence of computer-aided diagnosis (CAD) systems to
support clinicians in their decision-making process has risen,
enabling faster and more accurate diagnostic decisions with
lower variability. In particular, radiomics-driven CAD has
become an increasingly more prevalent area of research focus,
where radiomic sequences consisting of a large number of
image-based features are extracted and used to help clinicians
make more informed decisions, and provide a virtual second
opinion [1]. However, traditional radiomic sequences comprise
largely of generic, hand-crafted features, which may be limiting
in characterizing unique disease traits.
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Fig. 1. An overview of the proposed CLass-Enhanced Attentive Response
Discovery Radiomics (CLEAR-DR) system for interpretable computer-aided
diagnosis of diabetic retinopathy. For a new patient case, the patient’s retinal
fundus image is fed into the discovered deep radiomic sequencer and individual
attentive response maps are computed for each disease grade based on the
last layer of the sequencer. Based on this set of attentive response maps,
two different maps are computed: 1) a dominant attentive response map,
which shows the level of contribution of each location to the decision-making
process, and 2) a dominant class attentive map, which shows the dominant
grade associated with each location influencing the decision-making process.
Finally, the dominant attentive response map and the dominant attentive class
map are combined to produce the final CLEAR-DR map for a given retinal
fundus image, thus enabling the clinician to visualize the factors taken by the
proposed system in predicting disease grades.
More recently, the concept of Discovery Radiomics has
been shown to be particularly promising for oncology decision
support by directly discovering radiomic sequencers based on
medical imaging data [5], resulting in radiomic sequences
that are tailored to characterizing unique disease traits. A
particularly powerful use of Discovery Radiomics is for the
discovery of deep radiomic sequencers, which leverage deep
neural network (DNN) architectures to learn and extract subtle,
latent features associated with key disease characteristics. Such
DNN-based approaches have shown considerable promise in
detecting diabetic retinopathy [3], [9].
One of the main limitations of this approach is that it is
very difficult to gain insight or rationale as to how decisions
are made. This limits its utility to clinicians and hinders
widespread adoption in clinical settings. Quantitative metrics
such as accuracy or AUC do not convey any information about
how a particular deep radiomic sequencer makes decisions, thus
they are often labeled as uninterpretable “black boxes”. There
is a vital need for complimentary decision support systems
that can help and aid clinicians in understanding the decision
making process of deep radiomic sequencers.
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Fig. 2. Three different scenarios for grading diabetic retinopathy: 1) without CAD, 2) CAD system without interpretability, 3) interpretable CAD via
CLEAR-DR. The proposed CLEAR-DR system improves clinical interpretability by providing effective visual interpretations of the decision-making process.
The CLEAR-DR maps allows for the visualization of i) the attentive regions of interest responsible for grading decisions made by the deep radiomic sequencer;
ii) their level of contribution to the grading decision; and iii) the dominant grade associated with each attentive region of interest. This visualization enables
clinicians to better understand the rationale behind the grading decision made by the deep radiomic sequencer.
Some recent work pertaining to the interpretability and
understanding of the inner working of DNNs has been
developed in the context of convolutional neural networks
for generic visual recognition tasks. For example, Zeiler and
Fergus[10] proposed the use of an inverse parallel network
known as a deconvolutional network paired with a CNN to
visualize its features. The deconvolutional network re-projects
the activations from the higher-level latent space back to the
input such that they can be visualized in the image domain.
Springenberg et al. [8] proposed a visualization method known
as guided backpropagation where only positive gradients were
allowed to flow through backpropagation. In [11] Zhou et
al. proposed the class activation map (CAM) based on adding
a global average pooling layer to the network to be visualized.
CAMs are formed using only a single forward propagation
though they only provide a rough estimation map of attentive
regions. Montavon et. al. [7] proposed a method based on
Taylor expansion to improve the sharpness of the visualization.
All of the these methods however, only highighlight the regions
of attention and provide no meaning to the assignments other
than that they should form a coherent set of interpretable
pixels, primarily of convolutional, ReLU, and max-pooling
layers. Recently, Gondal et.al. [2] leveraged CAM maps to
highlight the lesion areas for diabetic retinopathy; however,
this approach provides no interpretation of grading information
and thus is limited in providing clinical insight on grading
decisions.
Motivated by the need for clinical interpretability, we propose
CLEAR-DR, a novel interpretable CAD system based on
the notion of CLass-Enhanced Attentive Response Discovery
Radiomics for the purpose of clinical decision support for
diabetic retinopathy. CLEAR-DR not only generates discrim-
inative radiomic sequences for making grading decisions for
diabetic retinopathy as a use case, but also visually interpret and
understand these decisions via information back-propagation.
The back-propagation is done through the discovered radiomic
sequencer by embedding the CLEAR approach proposed by
Kumar et. al. [6]. This process is designed to enable grade-
level interpretability. As shown in Fig. 2, CLEAR-DR can also
help in reducing inter-observer variability and intra-observer
variability while speeding up the overall diagnostic process. The
main contribution of the proposed CLEAR-DR CAD system
is as follows:
• To the best of the authors’ knowledge, this is the first
interpretable deep radiomic sequencer-driven CAD system
proposed that enables the visualization of multi-class
grading processes.
• The study shows a direct qualitative correlation between
the medically relevant landmarks that human experts use
for diabetic retinopathy grading and the landmarks used by
CLEAR-DR for classifying different grades of diabetics
through retinopathy images.
II. CLASS ENHANCED ATTENTIVE RESPONSE FOR
DIABETIC RETINOPATHY (CLEAR-DR)
This section explains the procedure for creating the proposed
interpretable CLEAR-DR CAD system. The procedure can be
explained in two parts: First, discovery of a deep radiomic
sequencer via Discovery Radiomics and second, creating the
CLEAR-DR maps for visually interpreting the decision making
process of the discovered deep radiomic sequencer. Both parts
are explained below.
A. Discovering the Deep Radiomic Sequencer for Diabetic
Retinopathy
To discover the aforementioned deep convolutional radiomic
sequencer, we construct a deep Convolutional Neural Network
(CNN) architecture for the radiomic sequencer discovery
process, where the radiomic sequencer is directly embedded in
the sequencer discovery architecture and learned based on the
available retinal fundus imaging data, and clinician-provided
ground truth labels for diabetic retinopathy. An overview of the
radiomic sequencer discovery architecture is shown in Fig. 3.
The receptive fields in the convolutional sequencing layers of
the radiomic sequencer are learned in a supervised manner
based on the input retinal fundus imaging data. This process
allows us to learn specialized receptive fields in the custom
radiomic sequencer that better characterize the unique diabetic
retinopathy grading characteristics.
3B. Creating the CLEAR-DR Map
After the deep radiomic sequencer discovery, we create
interpretable maps for CLEAR-DR system, called CLEAR-DR
maps. CLEAR-DR maps present two sets of information. First,
they present the regions in the diabetic retinopathy image,
along with their level of influence, that are responsible for the
decision made by the radiomic sequencer. Second, it presents
the dominant grade associated with the above aforementioned
regions. The procedure for creating the CLEAR-DR maps
is shown in Fig. 1, which can be explained as follows: First,
individual attentive response maps are computed for each kernel
associated with a grade by back-projecting activations from
the output layer of the deep radiomic sequencer. Based on this
set of attentive response maps, two different types of maps are
computed: 1) a dominant attentive response map, which shows
the dominant attentive level for each location in the image; and
2) a dominant class attentive map, which shows the dominant
grade involved in the decision-making process at each location.
Finally, the dominant attentive response map and the dominant
attentive grade map are combined visually by using color and
intensity to produce the final CLEAR-DR map.
As the proposed method extends upon the CLEAR approach,
for better understanding we keep the same notation as described
by Kumar et.al. [6]. The first step of CLEAR-DR map is to
compute a set of individual attentive response maps, which
we will denote as {R(x|d)|1 ≤ d ≤ N}, where N is the
number of grades in diabetic retinopathy. This is achieved
by back-propagating the responses of each kernel in the last
convolutional layer of the deep radiomic sequencer. To explain
the formulation, first consider a single layer of a deep radiomic
sequencer. Let hˆl be the deconvolved output response of the
single layer l with K kernel weights w. The deconvolution
output response at layer l then can be then obtained by
convolving each of the feature maps zl with kernels wl and
summing them as: hˆl =
∑K
k=1 zk,l∗wk,l. Here ∗ represents the
convolution operation. For notational brevity, we can combine
the convolution and summation operation for layer l into a
single convolution matrix Gl. Hence the above equation can
be denoted as: hˆl = Glzl.
For multi-layered sequencers, we can add an additional un-
pooling operation U . Thus, we can calculate the deconvolved
output response from feature space to input space for any layer
l in a multi-layer sequencer as:
Rl = G1U1G2U2....Gl−1Ul−1Glzl (1)
For CLEAR-DR maps, we specifically calculate the output
responses from individual kernels of the last layer of the
sequencer. Hence, given a network with last layer L containing
K = N kernels, we can calculate the attentive response map;
R(x|c) (where x denotes the response back-projected to the
input layer, and thus an array the same size as the input) for
any grade-specific kernel c (1 ≤ c ≤ N ) in the last layer as:
R(x|d) = G1U1G2U2....GL−1UL−1GdLzL. (2)
Here GdL represents the convolution matrix operation in
which the kernel weights wL are all zero except that at the dth
location.
Given the set of individual attentive response maps, we then
compute the dominant attentive class map, Cˆ(x), by finding
N:32
F:3x3
N:32
F:3x3
N:64
F:3x3
N:64
F:3x3
N:96
F:1x1
N:128
F:3x3
N:5
F:1x1
GAP
softmax
Convolutional 
block
Max-pooling
S: 2x2, Pool:2x2
Deep Radiomic CNN sequencer
Fig. 3. Architecture of the convolutional radiomic sequencer used in the deep
radiomic sequencer discovery process. The radiomic sequencer is embedded in
the sequencer discovery process, which augments a set of fully convolutional
layers, a rectified linear unit layer, max-pooling, global average pooling (GAP)
and a loss layer at the end of the sequencer for the learning process.
the class at each pixel that maximizes the attentive response
level, R(x|d), across all classes:
Cˆ(x) = argmax
c
R(x|d). (3)
Given the dominant attentive class map, Cˆ(x), we can now
compute the dominant attentive response map, DCˆ(x), by
selecting the attentive response level at each pixel based on the
identified dominant grade, which can be expressed as follows:
DCˆ(x) = R(x|Cˆ). (4)
To form the final CLEAR-DR map, we map the dominant
grade attentive map and the dominant attentive response map
in the HSV color space as follows:
H = F (Cˆ(x));S = 1;V = DCˆ(x) (5)
Here F (.) is the color map dictionary that assigns an
individual color to each dominant attentive grade, d. Fig. 1
shows an example of the CLEAR map overlayed on the image.
III. EXPERIMENTS AND RESULTS
This section presents the experimental setup and the qualita-
tive experiments performed to show the efficacy of the CLEAR-
DR maps via the discovery radiomics framework. We conducted
experiments on the Kaggle diabetic retinopathy dataset [4]
using a CNN-based deep radiomic sequencer. Details about
the dataset, training and creation of CLEAR-DR maps are
explained below.
A. Kaggle Diabetic Retinopathy Dataset
The Kaggle diabetic retinopathy dataset [4] consists of
high-resolution retinal fundus images with varying degrees
of illumination conditions captured using different types of
cameras. The retinal fundus images in the dataset were clinically
annotated with five different grades related to the presence of
diabetic retinopathy. The five grades of diabetic retinopathy
are as follows: 0: Negative, 1: Mild, 2: Moderate, 3: Severe,
and 4: Proliferative. The dataset consists of images from both
right and left eyes. Mild noise is present in both the images
and ground truth labels.
B. Experimental Setup: Training Discovery Radiomics Se-
quencer
To create and train a deep radiomic sequencer for diabetic
retinopathy, we use a CNN as shown in Fig. 3. To train this deep
radiomic sequencer, we selected retinal fundus images for one
eye (right) only and performed an automatic selective cropping
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Fig. 4. Correctly (a) and Mis-classified (b) examples for all diabetic retinopathy
grades. Each color represents a single grade, as identified by the color map
at the bottom of the figure. As well, the red box indicates the most attentive
region used for grade prediction. It can be observed that the attentive regions
used by the deep radiomic sequencer for making correct decisions corresponds
to medically relevant landmarks, thus providing additional evidence for the
proposed prediction. Best viewed in color and zoomed in.
to remove the background information. The use of a single
eye led to 53,354 images in total. For evaluation purposes,
we divided the dataset into 90% and 10% of the dataset for
training and testing respectively. We also performed horizontal
and vertical flipping along with channel-wise normalization
for the whole dataset as data augmentation. Using the above
setup, we trained the deep radiomic sequencer and achieved
an accuracy of 73.2% overall. It is important to note here that
the goal of this study is to create an interpretable system for
diabetic retinopathy, and thus the focus is on interpretability
of grading decisions made using the deep radiomic sequencer.
As such, the accuracy of the proposed CAD system can be
improved further by leveraging alternative DNN architectures
and other optimization approaches.
C. Qualitative Experiments: CLEAR-DR for Interpretable CAD
To demonstrate the efficacy of interpretability with the
CLEAR-DR system, we took the above discovered deep
radiomic sequencer and created CLEAR-DR maps using the
procedure shown in Fig. 1 for all diabetic retinopathy grades for
both scenarios i.e., cases where the CLEAR-DR CAD system
correctly predicts a diabetic’s grade (Fig. 4(a)) and cases where
it failed to identify the correct grade (Fig. 4(b)). Observing
the individual cases in Fig. 4, it is evident that CLEAR-DR
maps are able to explain both scenarios i.e., where the grade
was either correctly or mis-classified. For both scenarios, it
provides the attention areas thus giving a rationale in both
cases for particular decisions that the clinician can reason with.
Other specific observations can also be made from Fig. 4.
For example, in the correctly classified diabetic retinopathy
case in Fig. 4(a), it can be observed that the deep radiomic
sequencer mainly focuses on the veins near the eye-balls in the
retinal fundus image as there is an absence of abnormalities.
A similar observation about the abnormality and the extent
of it can be made in other correctly identified cases. In the
mis-classified case of mild diabetic retinopathy in Fig. 4 (b), it
can be seen the deep radiomic sequencer fails to focus on the
correct abnormalities in the though it identifies the abnormality,
it considers it as proliferative case.
Based on these results and observations, it is evident that
CLEAR-DR maps show a direct correlation between the
medically relevant landmarks for identifying the condition
of diabetic retinopathy and the attentive areas used by the
CLEAR-DR CAD system for grading diabetic retinopathy.
Thus, we argue that the CLEAR-DR maps are effective for
understanding and interpreting the classification decisions made
by a CAD system and also for providing a reason for their
decision making process in clinical settings.
IV. CONCLUSION
In this study, we proposed CLEAR-DR, an interpretable
CAD system via Discovery Radiomics. Using the Class-
Enhanced Attentive Response (CLEAR) approach, we created
a system based on discovery of a deep radiomic sequencer
that not only generates discriminating radiomic sequences for
diabetic retinopathy grading but also provides a mechanism
to visually interpret its decision making process. Qualitative
experiments show a direct correlation between the medically
relevant landmarks used by human experts for grading and the
visual features identified and used by the CLEAR-DR system
for diabetic retinopathy grading. Thus, the proposed approach
has great potential to reduce inter- and intra-observer variability
and to accelerate the overall screening and diagnosis process
while improving consistency and accuracy in clinical settings.
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